Evkeeza 1,200 mg/8 mL (150 mg/mL) injection Images
Generic Name: evinacumab
This medication has been identified as Evkeeza 1,200 mg/8 mL (150 mg/mL) injection. It is supplied by Regeneron Pharmaceuticals, Inc.
Evkeeza is used in the treatment of High Cholesterol, Familial Homozygous and belongs to the drug class miscellaneous antihyperlipidemic agents. Evkeeza 1,200 mg/8 mL (150 mg/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Evkeeza
- Generic Name
- evinacumab
- Strength
- 1,200 mg/8 mL (150 mg/mL) injection
- Availability
- Prescription only
- Drug Class
- Miscellaneous antihyperlipidemic agents
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Regeneron Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 61755-0010
More about Evkeeza (evinacumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antihyperlipidemic agents
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
